Navigation Links
AtheroNova Rodman & Renshaw Presentation Now Online at www.AtheroNova.com
Date:9/26/2011

/li>
  • Decreasing plasma LDL cholesterol levels
  • Upregulating ABCA1/ABCG1 gene expression
  • Increasing the efficiency of HDL
  • Potential Plaque Reversibility
  • Stimulate Reverse Cholesterol Transport
  • Atheroprotective Effects

  • As well as updates on the Company's innovative Drug Development Pipeline which currently encompasses:AHRO-001

    Enteric coated tabletAHRO-002

    Enteric stepwise therapeuticAHRO-003

    Statin combinationAHRO-200

    Dialysate additiveAHRO-100

    Obesity treatmentAHRO-010

    Dissolution of lipomasAHRO-300

    Localized transdermal fat dissolution Information is also presented on the Company's recently announced agreement with the Maxwell Biotech Group ("Maxwell") to license commercialization rights for AtheroNova's AHRO-001 lead atherosclerotic plaque regression compound. Maxwell, with funding provided by the Maxwell Biotech Venture Fund, Russia's premier biotech venture capital firm, will become equity investors in AtheroNova and commit to fund Phase I and Phase II human clinical studies in Russia. In return for this investment, AtheroNova will issue up to $4.1 million in common stock and grant to Maxwell an exclusive license to develop and commercialize AHRO-001 in the territory encompassing the Russian Federation, Belorussia, Ukraine, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Moldova, Azerbaijan and Armenia

    About AtheroNovaAtheroNova Inc., through its wholly-owned subsidiary, AtheroNova Operations, Inc., is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits.  The Company's focus on compounds to reduce or eliminate atherosclerotic plaque deposits addresses the most lucrative segments of the multi-billion dollar prescription drug market: cardiovascular disease and stroke prevention.  www.Athero
    '/>"/>

    SOURCE AtheroNova Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Palatin Technologies, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference
    2. Tengion to Present at Rodman & Renshaw 13th Annual Healthcare Conference
    3. Omeros to Present at Rodman and Renshaw 13th Annual Healthcare Conference
    4. ChromaDex to Present at the Rodman & Renshaw Annual Global Investment Conference
    5. Hadasit to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13, 2011
    6. Huifeng Bio-Pharmaceutical Technology, Inc. to Present at the 2011 Rodman & Renshaw Annual China Investment Conference in Shanghai
    7. ShengdaTech to Present at Rodman & Renshaw Annual China Investment Conference in Shanghai
    8. NeoStem to Present at Rodman & Renshaws 12th Annual Healthcare Conference
    9. WaferGen Corporate Presentation to be Webcast at Rodman and Renshaws 12th Annual Healthcare Conference
    10. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
    11. Weikang Bio-Technology to Present at Rodman and Renshaws Annual Global Investment Conference on September 14th 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... Eckert & Ziegler Vitalea Science (EZVS), ... to the pharmaceutical and biotech industry, has announced that ... the position of Director of Science & Technology. , ... experience in drug metabolism and bioanalysis to EZVS in ...
    (Date:1/22/2015)... GEA Niro Soavi the leader in ... the PandaPLUS 2000, which is ideal for new applications ... cell disruption . This compact laboratory homogenizer is the ... food, food additives and ingredients as well as for ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 The laboratory ... that has witnessed a number of technological advancements due ... regulatory requirements, growing need to integrate healthcare systems, and ... ease challenges in system integration. Key players in the ...
    (Date:1/22/2015)... 2015 Pipette.com has added the ... comprehensive portfolio of Eppendorf products. , The Eppendorf Centrifuge ... Centrifuge 5424/5424 R and receive the following:, ... plus or Eppendorf Reference 2 ,     3 ...
    Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2
    ... Holdings, Inc. (Pink Sheets: RPPR ) is ... Inc., has retained the services of Mr. Ed Ellsworth ... assist with the development and positioning of the numerous ... comes to SUTIMCo straight from Beckman Coulter (NYSE: ...
    ... 2011 Anthera Pharmaceuticals, Inc. (Nasdaq: ... sell shares of its common stock in an underwritten public ... option to purchase up to an additional 15% of the ... cover over-allotments, if any.  Citi and Leerink Swann LLC are ...
    ... EXTON, Pa., June 2, 2011 Morphotek®, Inc., a ... commenced a multi-center, phase II study of MORAb-004 for ... MORAb-004, a potentially first-in-class monoclonal antibody that specifically binds ... therapy comparing its safety and therapeutic activity at two ...
    Cached Biology Technology:AquaStar Holdings, Inc. Subsidiary Appoints Former Beckman Coulter Executive as Vice President of Operations 2Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock 3Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 2Morphotek®, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma 3
    (Date:1/22/2015)... NEW YORK and POINT ROBERTS, Washington ... global news source covering leading sectors including technology and tech ... Personal Privacy marketplace featuring master pickpocket and security consultant ... wallet is stolen and talks about the Wocket™ biometric smart ...
    (Date:1/22/2015)... Jan. 22, 2015   EyeLock, Inc. , a market leader ... Steve Gerber to the new role of Senior ... for leading development of mobile platforms and wearable solutions for ... and innovation in the semiconductor industry to his role at ...
    (Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... of the "The Global Watermarking and Fingerprinting ... http://photos.prnewswire.com/prnh/20130307/600769 This ... media watermarking and fingerprinting markets. Watermarking aims to ...
    Breaking Biology News(10 mins):Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2The Global Watermarking and Fingerprinting Markets 2
    ... Cowman has won the Mahathir Science Award in Tropical ... the Academy of Sciences Malaysia, in recognition of his ... Foundation chairman Tun Ahmad Sarji Abdul Hamid made the ... to the global malaria research effort, leading studies into ...
    ... November 7, 2013 The knowledge and skills required to ... unavailable to those living with financial limitations. Competing demands ... achieving better diets. However, two researchers at the ... at the effects that three educational sessions might have ...
    ... associated with hydrocarbon extraction can negatively affect aquatic ... in the open-access journal PLOS ONE ... and other institutions. Hydrocarbons are a primary ... exploration and extraction are profitable enterprises, hydrocarbons contribute ...
    Cached Biology News:Professor Alan Cowman wins Malaysian science award 23 'hands on' nutrition classes -- Enough to impact health behaviors in lower income women 2Drilling for hydrocarbons can impact aquatic life 2
    BD IMagnet 1 each...
    Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
    ... active MW: 34.2kDa Formulation: 10mM HEPES, ... 1mM dithiothreitiol with 50% glycerol Properites: ... the Certificate of Analysis for individual ... precipitation followed by gel filtration and ...
    Supplemental reagent for annexin V assay....
    Biology Products: